Skip to main content
×
×
Home

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study

  • Sophia Frangou (a1), Michael Lewis (a2) and Paul McCrone (a2)
Abstract
Background

Epidemiological and clinical studies suggest that increased intake of eicosapentaenoic acid (EPA) alleviates unipolar depression.

Aims

To examine the efficacy of EPA in treating depression in bipolar disorder.

Method

In a 12-week, double-blind study individuals with bipolar depression were randomly assigned to adjunctive treatment with placebo (n=26) or with 1g/day (n=24) or 2 g/day (n=25) of ethyl-EPA. Primary efficacy was assessed by the Hamilton Rating Scale for Depression (HRSD), with changes in the Young Mania Rating Scale and Clinical Global Impression Scale (CGI) as secondary outcome measures.

Results

There was no apparent benefit of 2g over 1g ethyl-EPA daily. Significant improvement was noted with ethyl-EPA treatment compared with placebo in the HRSD (P=0.04) and the CGI (P=0.004) scores. Both doses were well tolerated.

Conclusions

Adjunctive ethyl-EPA is an effective and well-tolerated intervention in bipolar depression.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study
      Available formats
      ×
Copyright
Corresponding author
Dr Sophia Frangou, Section of Neurobiology of Psychosis, PO66, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK. E-mail: s.frangou@iop.kcl.ac.uk
Footnotes
Hide All

This paper was presented at the 3rd European Stanley Foundation Conference on Bipolar Disorder, Freiburg, Germany, 12–14 September 2002.

Declaration of interest

The study (excluding attendance or presentations at international conferences) was supported by Laxdale Ltd, supplier of the ethyl-EPA preparation used in it.

Footnotes
References
Hide All
Adams, P. B., Lawson, S., Sanigorski, A., et al (1996) Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids, 31 (suppl. 1), 157161.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
Chang, M. C. & Jones, C. R. (1998) Chronic lithium treatment decreases brain phospholipase A2 activity. Neurochemical Research, 23, 887892.
Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, NJ: Lawrence Earlbaum.
Compton, M. T. & Nemeroff, C. B. (2000) The treatment of bipolar depression. Journal of Clinical Psychiatry, 61 (suppl. 9), 5767.
Finnen, M. J. & Lovell, C. R. (1991) Purification and characterisation of phospholipase A2 from human epidermis. Biochemical Society Transactions, 19 (suppl), 91.
First, M. B., Spitzer, R. L., Gibbon, M., et al (1994) Structured Clinical Interview for Axis 1 DSM–IV Disorders (Patient Edn) (SCID–1/P), Version 2.0. New York: Psychiatric Research Institute.
Guy, W. (2000) Clinical Global Impression. In Handbook of Psychiatric Measures (eds Rush, A. J., Pincus, H. A., First, M. B., et al), pp. 218222. Washington, DC: APA.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.
Hibbeln, J. R. (1998) Fish consumption and major depression. Lancet, 351, 1213.
Horrobin, D. F. & Peet, M. (2001) Adose-ranging study of ethyl-eicosapentaenoate in treatment-unresponsive depression. Biological Psychiatry, 49 (suppl), 37.
Keck, P. E. J., Welge, J. A., McElroy, S. L., et al (2000) Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biological Psychiatry, 47, 748755.
Kinrys, G. (2000) Hypomania associated with omega-3 fatty acids. Archives of General Psychiatry, 57, 715716.
Macqueen, G. M., Young, L. T. & Joffe, R. T. (2001) A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatrica Scandinavica, 103, 163170.
Nemets, B., Stahl, Z. & Belmaker, R. H. (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry, 159, 477479.
Noaghiul, S. & Hibbeln, J. R. (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorder. American Journal of Psychiatry, 160, 22222227.
Peet, M., Horrobin, D. F. & E-E Multicentre Study Group (2002) A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. Journal of Psychiatric Research, 36, 718.
Puri, B. K., Counsell, S. J., Richardson, A. J., et al (2002) Eicosapentaenoic acid in treatment-resistant depression. Archives of General Psychiatry, 59, 9192.
Seung Kim, H. F., Weeber, E. J., Sweatt, J. D., et al (2001) Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro . Molecular Psychiatry, 6, 246248.
Stoll, A. L. & Severus, W. E. (1996) Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes. Harvard Review of Psychiatry, 4, 7789.
Stoll, A. L., Severus, W. E., Freeman, M. P., et al (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Archives of General Psychiatry, 56, 407412.
Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity, and sensitivity. British Journal of Psychiatry, 133, 429435.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 42 *
Loading metrics...

Abstract views

Total abstract views: 159 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 25th June 2018. This data will be updated every 24 hours.

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study

  • Sophia Frangou (a1), Michael Lewis (a2) and Paul McCrone (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *